There have been 7 insider transactions during the 90-day period prior to the date of this filing from the activity of one insider all of which have been purchases and resulted in the acquisition of 1,100,000 company shares. This compares with the preceding 90-day window of time where there were 21 transactions from 2 insiders which resulted in the net acquisition of 1,555,000 shares.
This represents a lower level of transactions than the peer group average in the 150-company Pharmaceuticals peer group over the last 90-day period. Within the peer group activity averaged 40.3 transactions per company, and disposition of 6,966 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/944809/000120919119057066/xslF345X03/doc4.xml
|Market Chatter: ProSight Global Reportedly in Takeov...|
|Colony Capital's Convertible Senior Notes Offering E...|
|Insider Trends: 90-Days of Insider Buying at World A...|
|Durable Goods Orders Rise for Fourth Straight Month ...|
|Analyst Actions: BofA Securities Adjusts Brookfield ...|